MX2021002135A - Secuencia génica de gtpasa similar a dineína mitocondrial de tipo ii humana recombinante y usos de esta. - Google Patents
Secuencia génica de gtpasa similar a dineína mitocondrial de tipo ii humana recombinante y usos de esta.Info
- Publication number
- MX2021002135A MX2021002135A MX2021002135A MX2021002135A MX2021002135A MX 2021002135 A MX2021002135 A MX 2021002135A MX 2021002135 A MX2021002135 A MX 2021002135A MX 2021002135 A MX2021002135 A MX 2021002135A MX 2021002135 A MX2021002135 A MX 2021002135A
- Authority
- MX
- Mexico
- Prior art keywords
- nucleic acid
- gtpase
- human type
- mitochondrial dynein
- dynein
- Prior art date
Links
- 230000002438 mitochondrial effect Effects 0.000 title abstract 7
- 108090000623 proteins and genes Proteins 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 abstract 7
- 150000007523 nucleic acids Chemical class 0.000 abstract 7
- 102000039446 nucleic acids Human genes 0.000 abstract 7
- 108091006109 GTPases Proteins 0.000 abstract 6
- 102000013446 GTP Phosphohydrolases Human genes 0.000 abstract 4
- 208000001992 Autosomal Dominant Optic Atrophy Diseases 0.000 abstract 3
- 230000004927 fusion Effects 0.000 abstract 3
- 239000013604 expression vector Substances 0.000 abstract 2
- 238000003259 recombinant expression Methods 0.000 abstract 2
- 208000030533 eye disease Diseases 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 210000003470 mitochondria Anatomy 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 230000007119 pathological manifestation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
- C12Y306/03—Hydrolases acting on acid anhydrides (3.6) acting on acid anhydrides; catalysing transmembrane movement of substances (3.6.3)
- C12Y306/03005—Zn2+-exporting ATPase (3.6.3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
- C12Y306/05—Hydrolases acting on acid anhydrides (3.6) acting on GTP; involved in cellular and subcellular movement (3.6.5)
- C12Y306/05005—Dynamin GTPase (3.6.5.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810968173.0A CN110857440B (zh) | 2018-08-23 | 2018-08-23 | 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用 |
| PCT/CN2019/102352 WO2020038473A1 (zh) | 2018-08-23 | 2019-08-23 | 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021002135A true MX2021002135A (es) | 2021-06-23 |
Family
ID=69592310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021002135A MX2021002135A (es) | 2018-08-23 | 2019-08-23 | Secuencia génica de gtpasa similar a dineína mitocondrial de tipo ii humana recombinante y usos de esta. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11459584B2 (enExample) |
| EP (1) | EP3851535A4 (enExample) |
| JP (1) | JP7285022B2 (enExample) |
| KR (1) | KR102612148B1 (enExample) |
| CN (1) | CN110857440B (enExample) |
| AU (1) | AU2019323501B2 (enExample) |
| BR (1) | BR112021002566A2 (enExample) |
| CA (1) | CA3110153A1 (enExample) |
| MX (1) | MX2021002135A (enExample) |
| SG (1) | SG11202101236WA (enExample) |
| WO (1) | WO2020038473A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110857440B (zh) | 2018-08-23 | 2021-02-19 | 武汉纽福斯生物科技有限公司 | 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用 |
| CN111849998A (zh) * | 2020-07-29 | 2020-10-30 | 武汉纽福斯生物科技有限公司 | 编码人卵黄状黄斑病蛋白1的核酸分子及其应用 |
| CN117904156A (zh) * | 2022-10-17 | 2024-04-19 | 武汉纽福斯生物科技有限公司 | 人线粒体动力蛋白样gtp酶及应用 |
| WO2024226729A2 (en) * | 2023-04-26 | 2024-10-31 | Astellas Gene Therapies, Inc. | Compositions and methods for opa1 gene therapy |
| CN117304293B (zh) * | 2023-10-07 | 2025-08-08 | 浙江大学 | 一种鸡opa1抗原决定簇及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| AU7906691A (en) | 1990-05-23 | 1991-12-10 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Adeno-associated virus (aav)-based eucaryotic vectors |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6989264B2 (en) | 1997-09-05 | 2006-01-24 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| EP2369002A1 (en) | 1999-08-09 | 2011-09-28 | Targeted Genetics Corporation | Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| WO2006073496A2 (en) | 2004-07-30 | 2006-07-13 | Targeted Genetics Corporation | Recombinant aav based vaccine methods |
| PT1880008E (pt) * | 2005-05-03 | 2015-08-27 | Inserm Inst Nat De La Santé Et De La Rech Médicale | Expressão de proteína mitocondrial através de uma abordagem alotópica melhorada |
| EP2030021B1 (en) * | 2006-05-18 | 2012-11-21 | Andreas Reichert | Method for diagnosing mitochondrial dysfunction |
| CN102634527B (zh) * | 2012-04-11 | 2013-11-06 | 华中科技大学同济医学院附属同济医院 | 重组人nadh脱氢酶亚单位4基因及其表达载体构建方法 |
| JP2015527889A (ja) * | 2012-07-25 | 2015-09-24 | ザ ブロード インスティテュート， インコーポレイテッド | 誘導可能なｄｎａ結合タンパク質およびゲノム撹乱ツール、ならびにそれらの適用 |
| TW201514200A (zh) * | 2013-04-03 | 2015-04-16 | Aliophtha Ag | 用於治療由ｏｐａ１單倍體不足所造成的疾病之人工轉錄因子 |
| CN104450747B (zh) * | 2014-09-23 | 2018-02-09 | 武汉纽福斯生物科技有限公司 | 用于治疗Leber遗传性视神经病变的重组腺相关病毒‑NADH脱氢酶亚单位4基因全长以及药剂 |
| US20190275168A1 (en) * | 2015-04-30 | 2019-09-12 | The Trustees Of Columbia University In The City Of New York | Gene therapy for autosomal dominant diseases |
| WO2017191274A2 (en) * | 2016-05-04 | 2017-11-09 | Curevac Ag | Rna encoding a therapeutic protein |
| WO2018102672A1 (en) * | 2016-12-04 | 2018-06-07 | Alavi Khorassani Moghadam Marcel Victor | Methods for treating diseases related to mitochondrial stress |
| CN110392582A (zh) * | 2017-02-08 | 2019-10-29 | 弗里德里克·米谢尔生物医学研究所 | 用于使基因在视网膜神经节细胞中特异性表达的启动子SynP88 |
| CN111068071A (zh) * | 2018-10-22 | 2020-04-28 | 武汉纽福斯生物科技有限公司 | 基因治疗Leber遗传学视神经病变 |
| CN110857440B (zh) | 2018-08-23 | 2021-02-19 | 武汉纽福斯生物科技有限公司 | 重组人ⅱ型线粒体动力蛋白样gtp酶基因序列及其应用 |
-
2018
- 2018-08-23 CN CN201810968173.0A patent/CN110857440B/zh active Active
-
2019
- 2019-08-23 CA CA3110153A patent/CA3110153A1/en active Pending
- 2019-08-23 EP EP19851390.5A patent/EP3851535A4/en not_active Withdrawn
- 2019-08-23 WO PCT/CN2019/102352 patent/WO2020038473A1/zh not_active Ceased
- 2019-08-23 KR KR1020217008407A patent/KR102612148B1/ko active Active
- 2019-08-23 BR BR112021002566-9A patent/BR112021002566A2/pt not_active IP Right Cessation
- 2019-08-23 JP JP2021509904A patent/JP7285022B2/ja active Active
- 2019-08-23 MX MX2021002135A patent/MX2021002135A/es unknown
- 2019-08-23 SG SG11202101236WA patent/SG11202101236WA/en unknown
- 2019-08-23 AU AU2019323501A patent/AU2019323501B2/en active Active
-
2021
- 2021-02-23 US US17/182,903 patent/US11459584B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20210180086A1 (en) | 2021-06-17 |
| AU2019323501B2 (en) | 2023-08-03 |
| EP3851535A4 (en) | 2022-12-14 |
| EP3851535A1 (en) | 2021-07-21 |
| JP2021533801A (ja) | 2021-12-09 |
| CA3110153A1 (en) | 2020-02-27 |
| SG11202101236WA (en) | 2021-03-30 |
| CN110857440A (zh) | 2020-03-03 |
| JP7285022B2 (ja) | 2023-06-01 |
| CN110857440B (zh) | 2021-02-19 |
| BR112021002566A2 (pt) | 2021-06-22 |
| AU2019323501A1 (en) | 2021-02-25 |
| KR102612148B1 (ko) | 2023-12-12 |
| US11459584B2 (en) | 2022-10-04 |
| KR20210049131A (ko) | 2021-05-04 |
| WO2020038473A1 (zh) | 2020-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023001394A (es) | Genes del factor viii optimizados. | |
| SA522433360B1 (ar) | L-أَسْباراجيناز مُعدل | |
| MY176331A (en) | Carbohydrate degrading polypeptide and uses thereof | |
| MX2022008508A (es) | Enzimas y aplicaciones de las mismas. | |
| MX2022005236A (es) | Composiciones y metodos para el tratamiento de la perdida auditiva neurosensorial mediante el uso de sistemas de vectores duales de otoferlina. | |
| EA201491470A1 (ru) | Композиции фактора viii и способы получения и использования подобных | |
| NZ609903A (en) | Expression vector for high level expression of recombinant proteins | |
| SG10201906673WA (en) | Artificial nucleic acid molecules | |
| MX372992B (es) | Vector de virus adeno-asociado. | |
| CR20200236A (es) | Synpiii, un promotor para la expresión específica de genes en el epitelio pigmentario retiniano | |
| MX382218B (es) | Variantes de lipasa y polinucleotidos que las codifican. | |
| NZ629843A (en) | Identification of channelrhodopsin-2 (chop2) mutations and methods of use | |
| MX2009002816A (es) | Proteinas de fusion de albumina. | |
| NZ739286A (en) | Recombinant orf virus vector | |
| AU2015247777A8 (en) | Codon optimized nucleic acid encoding a retinitis pigmentosa GTPase regulator (RPGR) | |
| MX2015010078A (es) | Uso de polipeptidos con actividad proteasa en alimentos para animales. | |
| EP2589658A4 (en) | PARTIAL REGION POLYPEPTIDE OF REIC / DKK-3 PROTEIN | |
| EP3760713A3 (en) | Lipase variants and polynucleotides encoding same | |
| MX2016006277A (es) | Secuencia de endolisina kz144 modificada. | |
| MX2021013879A (es) | Variantes de lipasa y polinucleotidos que las codifican. | |
| NZ752941A (en) | Frataxin expression constructs | |
| BR112016011095A2 (pt) | Sequência de endolisina el188 modificada | |
| MX2024013403A (es) | Variantes de gpr156 y usos de estas | |
| EA201890274A1 (ru) | Векторная система из аденовируса 9 птиц (fadv-9) и связанные способы | |
| AR101146A1 (es) | Proteína con actividad xilanasa |